To amend title XXVII of the Public Health Service Act and title XIX of the Social Security Act to require coverage of Alzheimer's biomarker testing under group health plans, group and individual health insurance coverage, and the Medicaid program.

U.S. Congress · HR9823 · In Committee

Progression

Timing in context

Primary sponsor's contributions received (same period)

Adjacency in time is shown for context; it is not evidence of cause. Funded ≠ false — see the methodology.

What the bill says

HR9823 · U.S. Congress · In Committee

Introduced 2026-07-22. Latest action: Referred to the House Committee on Energy and Commerce.

View on Congress.gov →

Sponsors

What analysts say

No nonpartisan analysis on file for this measure yet.

What politicians say

No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.

Action History

DateAction
2026-07-22Introduced in House
2026-07-22Referred to the House Committee on Energy and Commerce.

← Back to legislation